-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) Misses Q1 EPS by 14c
-
-
-
-
-
-
-
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOLĀ® (propranolol hydrochloride) Oral Solution
-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 4c
-
-
-
-
-
-
-
Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
-
-
-
-
-
-
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
-
-
-
-
-
-
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
1,219,415 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

